Research Article
Species Diversity, Antifungal Susceptibility, and Virulence Attributes of Candida Colonising the Oral Cavities of Adult Diabetic Patients
Table 4
Antifungal susceptibility pattern of the isolates.
| | Species | Amphotericin B | Ketoconazole | Fluconazole | Voriconazole |
| | C. albicans () | | | | | | Diabetes: 26 | S-26 | S-26 | S-26 | S-26 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 18 | S-18 | S-18 | S-18 | S-18 | | R-0 | R-0 | R-0 | R-0 | | C. tropicalis () | | | | | | Diabetes: 8 | S-8 | S-8 | S-8 | S-8 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 1 | S-1 | S-1 | S-1 | S-1 | | R-0 | R-0 | R-0 | R-0 | | C. krusei () | | | | | | Diabetes: 7 | S-7 | S-7 | S-0 | S-7 | | R-0 | R-0 | R-7 | R-0 | | Healthy: 0 | — | — | — | — | | C. parapsilosis () | | | | | | Diabetes: 4 | S-4 | S-4 | S-4 | S-4 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 1 | S-1 | S-1 | S-1 | S-1 | | R-0 | R-0 | R-0 | R-0 | | C. glabrata () | | | | | | Diabetes: 2 | S-2 | S-2 | S-1 | S-2 | | | | SDD-1 | | | R-0 | R-0 | R-0 | R-0 | | Healthy: 3 | S-3 | S-3 | S-3 | S-3 | | R-0 | R-0 | R-0 | R-0 | | C. magnoliae () | | | | | | Diabetes: 1 | S-1 | S-1 | SDD-1 | S-1 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 0 | — | — | — | — | | C. kefyr () | | | | | | Diabetes: 1 | S-1 | S-1 | S-1 | S-1 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 0 | — | — | — | — | | C. rugosa () | | | | | | Diabetes: 1 | S-1 | S-1 | SDD-1 | S-1 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 0 | — | — | — | — | | Others | | | | | | Trichosporon asahii () | | | | | | Diabetes: 1 | S-1 | S-1 | SDD-1 | S-1 | | R-0 | R-0 | R-0 | R-0 | | Healthy: 0 | — | — | — | — |
|
|
S: sensitive; R: resistant; SDD: susceptible dose dependent; Amphotericin B: sensitive (S) ≤ 0.5 g/mL, resistant (R) ≥ 1 g/mL; Fluconazole: sensitive (S) ≤ 8 g/mL, SDD 16–32 g/mL, resistant (R) ≥ 64 g/mL; Ketaconazole: resistant (R) ≥ 1 g/mL; Itraconazole (S) ≤ 0.125 g/mL, SDD 0.25–0.5, Resistant (R) ≥ 1 g/mL; Voriconazole (S) ≤ 1.
|
